S&P 500   3,110.29 (+0.22%)
DOW   27,875.62 (+0.39%)
QQQ   201.83 (+0.06%)
CGC   18.41 (-9.27%)
BABA   186.78 (+1.04%)
GE   11.55 (+0.17%)
T   37.75 (+0.40%)
ACB   2.70 (-13.46%)
F   8.89 (+2.07%)
PRI   130.63 (+0.14%)
NFLX   310.48 (-0.39%)
BAC   33.18 (+1.04%)
DIS   148.29 (+0.95%)
S&P 500   3,110.29 (+0.22%)
DOW   27,875.62 (+0.39%)
QQQ   201.83 (+0.06%)
CGC   18.41 (-9.27%)
BABA   186.78 (+1.04%)
GE   11.55 (+0.17%)
T   37.75 (+0.40%)
ACB   2.70 (-13.46%)
F   8.89 (+2.07%)
PRI   130.63 (+0.14%)
NFLX   310.48 (-0.39%)
BAC   33.18 (+1.04%)
DIS   148.29 (+0.95%)
S&P 500   3,110.29 (+0.22%)
DOW   27,875.62 (+0.39%)
QQQ   201.83 (+0.06%)
CGC   18.41 (-9.27%)
BABA   186.78 (+1.04%)
GE   11.55 (+0.17%)
T   37.75 (+0.40%)
ACB   2.70 (-13.46%)
F   8.89 (+2.07%)
PRI   130.63 (+0.14%)
NFLX   310.48 (-0.39%)
BAC   33.18 (+1.04%)
DIS   148.29 (+0.95%)
S&P 500   3,110.29 (+0.22%)
DOW   27,875.62 (+0.39%)
QQQ   201.83 (+0.06%)
CGC   18.41 (-9.27%)
BABA   186.78 (+1.04%)
GE   11.55 (+0.17%)
T   37.75 (+0.40%)
ACB   2.70 (-13.46%)
F   8.89 (+2.07%)
PRI   130.63 (+0.14%)
NFLX   310.48 (-0.39%)
BAC   33.18 (+1.04%)
DIS   148.29 (+0.95%)
Log in

Urogen Pharma Earnings Date, Estimates & History (NASDAQ:URGN)

$29.60
+0.70 (+2.42 %)
(As of 11/22/2019 04:00 PM ET)
Today's Range
$28.57
Now: $29.60
$29.63
50-Day Range
$20.92
MA: $23.49
$29.37
52-Week Range
$20.72
Now: $29.60
$55.49
Volume139,500 shs
Average Volume205,378 shs
Market Capitalization$618.55 million
P/E RatioN/A
Dividend YieldN/A
Beta1.12

Earnings

Urogen Pharma (NASDAQ:URGN) Earnings Information

Urogen Pharma last issued its earnings data on November 12th, 2019. The reported ($1.06) earnings per share for the quarter, topping analysts' consensus estimates of ($1.26) by $0.20. Urogen Pharma has generated ($4.80) earnings per share over the last year. Urogen Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2020 based off prior year's report dates.

Urogen Pharma Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Urogen Pharma (NASDAQ:URGN) Earnings Estimates

2019 EPS Consensus Estimate: ($5.73)
2020 EPS Consensus Estimate: ($3.98)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20191($1.30)($1.30)($1.30)
Q2 20191($1.34)($1.34)($1.34)
Q3 20192($1.49)($1.42)($1.46)
Q4 20192($1.64)($1.62)($1.63)
Q1 20201($1.23)($1.23)($1.23)
Q2 20201($1.60)($1.60)($1.60)
Q3 20201($0.98)($0.98)($0.98)
Q4 20201($0.17)($0.17)($0.17)

Urogen Pharma (NASDAQ URGN) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/27/2020
(Estimated)
       
11/12/2019Q3($1.26)($1.06)($1.06)Transcript
8/9/2019Q2 2019($1.20)($1.08)($1.08)$0.02 millionTranscript
5/9/20193/31/2019($1.12)($1.11)($1.11)Transcript
2/28/2019Q4 2018($1.29)($1.46)($1.46)Transcript
11/15/20189/30/2018($1.09)($1.28)($1.28)$0.28 millionN/A
8/14/20186/30/2018($0.89)($1.14)($1.14)$0.36 millionN/A
5/15/20183/31/2018($0.73)($0.88)($0.88)$0.48 millionN/A
3/15/2018n/a($0.65)($0.74)($0.74)$0.33 millionTranscript
11/14/2017Q3 2017$0.08($0.02)($0.02)$7.67 million$7.81 millionN/A
8/14/2017Q2 2017($0.46)($0.70)($0.70)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 11/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel